Radioiodine treatment for graves’ disease: a 10-year Australian cohort study

BACKGROUND: Radioactive iodine (I(131)) is a common definitive treatment for Graves’ Disease. Potential complications include worsening, or new development of Graves’ eye disease and development of a radiation thyroiditis. The purpose of the present study was to assess outcomes of patients treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanning, Erin, Inder, Warrick J., Mackenzie, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292026/
https://www.ncbi.nlm.nih.gov/pubmed/30541519
http://dx.doi.org/10.1186/s12902-018-0322-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292026/
https://www.ncbi.nlm.nih.gov/pubmed/30541519
http://dx.doi.org/10.1186/s12902-018-0322-7

Ejemplares similares